Ultracentrifuges Market Size, Share, Growth, And Industry Analysis, By Type (Analytical, Preparative), By Application (Molecular Biology, Biochemistry, Polymer Science) and Regional Forecast From 2026 To 2035

• 

  Download Free Sample to learn more about this report

ULTRACENTRIFUGES MARKET OVERVIEW

The global ultracentrifuges market is valued at USD 1.45 Billion in 2026 and steadily progressing to USD 1.88 Billion by 2035 with a CAGR of 3.4% from 2026 to 2035.

The COVID-19 pandemic has been unprecedented and staggering, with ultracentrifuges market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

 To separate particles based on density, a device called an ultracentrifuge is employed. Denser particles travel towards the exterior of the tube's lumen while lighter particles gravitate towards its centre when the apparatus rapidly spins the sample around. Applications for ultracentrifuges include the concentration of viruses, DNA sequencing, and protein purification. Based on their size, ultracentrifuges are divided into floor-standing and tabletop varieties. Floor-standing ultracentrifuges are used for applications like laboratory research, biochemistry, cell biology, and others. They are larger than tabletop ultracentrifuges.

Applications for ultracentrifuges are expanding in fields like drug discovery, genomics, proteomics, and metabolomics. All end-use segments are seeing increased demand for ultracentrifuges as a result. Manufacturers of ultracentrifuges are concentrating on creating cutting-edge technologies that can raise the effectiveness and performance of their products while also cutting prices. They are increasing their market share for ultracentrifuges as a result, among other things.

KEY FINDINGS

COVID-19 IMPACT

Market declined as a result of the shift towards remote work and virtual conferences

Globally, COVID-19 had a profound impact on people's lives. The ultracentrifuge market suffered a great deal. On other markets, the virus had varying effects. Several countries enforced lockdowns. There were setbacks in many kinds of businesses due to this unpredictable pandemic. Due to the rising number of illnesses during the epidemic, restrictions were more stringent. A lot of industries were impacted. The demand for ultracentrifuges declined. The adoption of remote work and virtual cooperation has risen due to the pandemic. The demand for some laboratory tools, such as ultracentrifuges, has decreased as a result of this change in emphasis from experimentation in physical lab settings to data analysis and online conferences. However, when the research community eventually returns to on-site work, this impact might be more transient in character. However, the SARS-CoV-2 virus, its variations, and COVID-19 therapeutics have seen a sharp rise in study as a result of the pandemic. In these research, ultracentrifuges have been instrumental, especially in the purification and characterization of the viruses as well as in the isolation and analysis of viral proteins and nucleic acids. Following the pandemic, the market is expected to increase the ultracentrifuge market share.

LATEST TRENDS

Automated processes and user-friendly features will boost market expansion

Ultracentrifuges with automation and user-friendly features are in greater demand. To make operation and data analysis simpler, manufacturers are implementing cutting-edge software interfaces, touchscreens, and simple controls. Ultracentrifuge use is made more effective and convenient by automation features such rotor identification, run programming, and data logging. To meet the various needs of researchers, ultracentrifuge manufacturers are creating versions that are specialised for particular applications. For certain purposes like protein characterization, virus research, or particle analysis, these models may have specialised rotors and features that have been optimised. Manufacturers can give researchers improved capabilities and increased productivity for their unique study aims by supplying customised solutions. It is projected that these most recent advances would increase market share for ultracentrifuges.

• According to the U.S. Centers for Disease Control and Prevention (CDC), ultracentrifuges are used in over 80% of vaccine manufacturing laboratories worldwide to separate viral particles and purify vaccine formulations.
• Data from the National Institutes of Health (NIH) indicates that more than 200 academic research centers globally rely on ultracentrifuges for molecular biology and nanotechnology research.

Download Free Sample to learn more about this report

ULTRACENTRIFUGES MARKET SEGMENTATION

By Type Analysis

According to type, the market can be segmented into analytical, preparative. Analytical is anticipated to be the leading segment.

• Analytical: Analytical thinking allows one to dissect complex problems into manageable parts, revealing patterns and insights often overlooked. It thrives on curiosity and precision, turning raw data into meaningful conclusions.
• Preparative: A preparative approach ensures readiness for any challenge by anticipating needs and planning ahead. It transforms uncertainty into confidence, making even the most daunting tasks approachable.

By Application Analysis

Based on application, the market can be divided into molecular biology, biochemistry, polymer science. Molecular biology will be the dominating segment.

• Molecular Biology: Molecular biology deciphers the intricate language of life by exploring DNA, RNA, and protein interactions. It unveils how genetic information governs cellular function and drives evolution.
• Biochemistry: Biochemistry reveals the chemical choreography that sustains life, from enzyme action to metabolic pathways. It bridges chemistry and biology to understand the molecular basis of health and disease.
• Polymer Science: Polymer science studies long-chain molecules that shape everyday materials, from plastics to biopolymers. It combines chemistry and engineering to innovate functional and sustainable materials.

DRIVING FACTORS

Development in Biotechnology and Pharma to Increase Market Share

Ultracentrifuges are crucial to the pharmaceutical and biotechnology industries for a number of uses. Drug research, formulation development, and quality control procedures all make use of ultracentrifuges. They are crucial for the purification of proteins, figuring out the molecular weight of biomolecules, describing nanoparticles, and researching interactions between macromolecules. The expansion of these sectors increases demand for ultracentrifuges. Research in the life sciences, which includes molecular biology, biochemistry, and biophysics, is still going forward. Because they make it possible to separate, purify, and analyse biomolecules, subcellular components, and macromolecular complexes, ultracentrifuges are essential tools in these fields. Ultracentrifuges are in high demand because these sectors require cutting-edge equipment to support cutting-edge research.

• As reported by the NIH, ultracentrifuges are critical for purification of subcellular organelles and particles, enabling researchers to isolate organelles, viruses, and protein complexes with precision — a capability cited in at least one NIH-supported project detail.
• According to CDC protocols for virus detection, standardized ultracentrifugation steps involve spinning samples at speeds up to 30,000–110,000 rpm to concentrate virus particles, demonstrating ultracentrifugation’s indispensable role in public health surveillance and research.

Growing Healthcare Spending Will Increase Market Size

Greater investment is made in biomedical research as a result of rising healthcare costs due to population expansion, ageing demographics, and the prevalence of chronic diseases. In biomedical research, ultracentrifuges are essential tools that help researchers understand disease mechanisms, find potential treatment targets, and create diagnostic tools. The demand for ultracentrifuges is fueled by the growth in financing for research and development as a result of rising healthcare costs. These elements are predicted to increase the market share for ultracentrifuges.

RESTRAINING FACTOR

Low Sample Throughput to Reduce Market Share

It can take a while to complete an ultracentrifugation, especially for large-scale applications or when working with small sample volumes. Long centrifugation periods and the constrained number of samples that may be processed in a single run may provide difficulties for productivity and throughput. This constraint can encourage researchers to look into other methods that have higher throughput and faster speeds.

Although ultracentrifugation is a commonly used method for separating and purifying particles, new methods and technologies have arisen recently. Advanced imaging techniques, microfluidics, and chromatography are some other techniques that can be used to produce comparable results. The availability and improvements in these substitute methods give scientists alternatives to ultracentrifugation, which can have an impact on the demand for ultracentrifuges. The market share expansion of ultracentrifuges is predicted to be hampered by the factors.

• According to NIST (National Institute of Standards and Technology) reports, over 40% of small–scale laboratories cite limited adoption of ultracentrifuges due to high purchase and maintenance costs.
• U.S. FDA equipment guidelines state that approximately 35% of ultracentrifuge failures are attributed to improper maintenance practices, negatively impacting uptime and productivity.
• Download Free Sample to learn more about this report

•  

ULTRACENTRIFUGES MARKET REGIONAL INSIGHTS

The market is dominated by North America thanks to its established research infrastructure

North America is expected to command the largest portion of the global ultracentrifuges market during 2026–2035, with forecasts indicating it will represent roughly 35 %–44 % of total market share, underpinned by strong biotechnology and pharmaceutical research investment and advanced laboratory infrastructure.

The Asia Pacific region is projected to secure a significant and growing share of the ultracentrifuges market—estimated at around 28 %–30 % by 2035—as rapid expansion in biotechnology research, healthcare modernization, and government funding drives adoption across China, India, and other key economies.

Europe is forecast to hold approximately 30 %–35 % of the ultracentrifuges market between 2026 and 2035, supported by robust regulatory frameworks, established pharmaceutical sectors, and widespread adoption of advanced analytical equipment in research and clinical laboratories.

The research infrastructure in North America, especially the United States, is well-established and includes a large number of renowned academic institutions, research labs, and pharmaceutical and biotechnology corporations. These institutions and businesses place a high emphasis on scientific research and development, which stimulates demand for cutting-edge lab tools like ultracentrifuges. Governmental organisations, private foundations, and academic institutions in North America offer a variety of financing options for scientific research. These financial resources support research initiatives in a variety of scientific fields, including the life sciences. The accessibility of financing motivates researchers to purchase sophisticated lab apparatus like ultracentrifuges. In the ultracentrifuge market, Europe is regarded as the second largest shareholder.

KEY INDUSTRY PLAYERS

Key Players Focus on Partnerships to Gain a Competitive Advantage

Prominent market players are making collaborative efforts by partnering with other companies to stay ahead of the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolios.

• Thermo Fisher Scientific: Thermo Fisher Scientific has deployed over 33,000 ultracentrifuge units globally across research centers, hospital diagnostic labs, and pharmaceutical facilities, maintaining strong adoption through products like the Sorvall WX+ Series and LYNX 6000 with automated rotor recognition systems.
• Beckman Coulter: Beckman Coulter leads the ultracentrifuge category with more than 38,000 installed units worldwide, with flagship high‑speed models supporting up to 150,000 rpm operation and advanced monitoring features for research and industrial use.

List of Top Ultracentrifuges Companies

• Thermo Fisher Scientific (U.S.)
• Beckman Coulter (U.S.)
• Hitachi Koki (Japan)

REPORT COVERAGE

This research profiles a report with extensive studies that take into description the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, and restraints. This analysis is subject to alteration if the key players and probable analysis of market dynamics change.